Eli Lilly (LLY -1.38%) is generating billions in cash flow growth due to product innovation.
*Stock prices used were the afternoon prices of Dec. 22, 2024. The video was published on Dec. 24, 2024.
Free Article
You're reading a free article with opinions that may differ from The Motley Fool's Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More
Is Eli Lilly an Undervalued Growth Stock to Buy Now?
By Parkev Tatevosian, CFA
–
Dec 24, 2024 at 7:30PM
NYSE: LLY
Eli Lilly
Market Cap
$743B
Today's Change
(-1.38%) -$10.97
Current Price
$783.17
Price as of December 27, 2024, 4:00 p.m. ET
Parkev Tatevosian, CFA has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. Parkev Tatevosian is an affiliate of The Motley Fool and may be compensated for promoting its services. If you choose to subscribe through his link, he will earn some extra money that supports his channel. His opinions remain his own and are unaffected by The Motley Fool.
Related Articles
Will This Major Pharmaceutical Stock Announce a Stock Split in 2025?
Billionaire Philippe Laffont Is Selling Artificial Intelligence Champion Nvidia and Piling Into These Two Industry Leaders
Is Eli Lilly Stock a Buy?
2 Pharmaceutical Growth Stocks to Buy Now and Hold for Decades
Better Buy: Eli Lilly vs. Novo Nordisk. The Answer Is Becoming Abundantly More Clear.
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.